Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
TXG holding history
10x Genomics, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TXG overviewAll 13F holders of TXGFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −102,272−100.0% | Sold out | Holders |
| Q1 2026 | 102,272 | $2.17M | <0.1% | +10,572+11.5% | Added | Holders |
| Q4 2025 | 91,700 | $1.50M | <0.1% | +40,701+79.8% | Added | Holders |
| Q3 2025 | 50,999 | $596.2K | <0.1% | −348,703−87.2% | Reduced | Holders |
| Q2 2025 | 399,702 | $4.63M | <0.1% | −17,749−4.3% | Reduced | Holders |
| Q1 2025 | 417,451 | $3.64M | <0.1% | +370,590+790.8% | Added | Holders |
| Q4 2024 | 46,861 | $672.9K | <0.1% | −420,262−90.0% | Reduced | Holders |
| Q3 2024 | 467,123 | $10.5M | <0.1% | +431,722+1,219.5% | Added | Holders |
| Q2 2024 | 35,401 | $688.5K | <0.1% | +35,401 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −7,516−100.0% | Sold out | Holders |
| Q4 2023 | 7,516 | $420.6K | <0.1% | +7,516 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −197,321−100.0% | Sold out | Holders |
| Q2 2023 | 197,321 | $11.0M | <0.1% | +197,321 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −19,268−100.0% | Sold out | Holders |
| Q4 2022 | 19,268 | $702.1K | <0.1% | +19,268 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −9,704−100.0% | Sold out | Holders |
| Q4 2021 | 9,704 | $1.45M | <0.1% | −287,639−96.7% | Reduced | Holders |
| Q3 2021 | 297,343 | $43.3M | 0.2% | +297,343 | New | Holders |